SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001341004-16-001183
Filing Date
2016-02-29
Accepted
2016-02-29 17:04:10
Documents
3
Period of Report
2016-02-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 VALEANT PHARMACEUTICALS INTERNATIONAL, INC. FORM 8-K form8k.htm 8-K 31541
2 PRESS RELEASE ex99_1.htm EX-99.1 22017
3 logo.jpg GRAPHIC 17093
  Complete submission text file 0001341004-16-001183.txt   78710
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 161469236
SIC: 2834 Pharmaceutical Preparations